HyClone is a global manufacturer of sera, liquid and powdered media, sterile liquids, and sterile liquid handling systems to support research and production of biopharmaceuticals. HyClone, headquartered in Logan, Utah, is owned by Fisher Scientific International. Logan locations include manufacturing facilities for sera, dry powdered media, liquid media, process liquids, and disposable BioProcess Containers (BPCs) as well as warehouses and a main distribution center. Research and Product Development as well as Design Engineering are also centered in Logan. Other North American operations include an automated BPC manufacturing site in Novato, California and multiple blood collection and serum processing sites at abattoirs throughout the United States. HyClone serum collection and processing are also done in Canada. Global markets are serviced through serum processing sites in New Zealand and Australia and a liquid media and BPC production site in Cramlington, England. International sales and distribution offices and warehouses are located in Aalst, Belgium; Hong Kong; and Beijing, China. HyClone is registered with the US Food and Drug Administration as a Class I Medical Device Manufacturer and operates in accordance with current Good Manufacturing Practice (cGMP) requirements as described in 21 C.F.R. §820 et seq. HyClone is also certified as an ISO 9001:2000 supplier.
Mediatech, a privately held company, is a leading manufacturer of life science products with a portfolio of trademarked items including cellgro. As a registered FDA device establishment, products are sold via a network of distributors and twenty Mediatech Account Representatives. Through a diverse line of high quality products incorporating innovative technology and packaging media, Mediatech seeks to meet the specific needs of its customers. The company's principal end-users are renowned research and biotechnology institutions and pharmaceutical corporations that utilize Mediatech's products in pioneering research to treat human and animal diseases. Mediatech is deeply involved in the production of cellular transplantation processing materials.
Cambrex Corporation is a life sciences company engaged primarily in the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry. Products and services are supplied globally to generic drug companies. Cambrex primarily supplies its products and services to pharmaceutical and generic drug companies. The Company's products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates for use in the production of prescription and over-the-counter drug products and other fine custom chemicals derived from organic chemistry. Cambrex completed the sale of the businesses that comprised the Bioproducts and Biopharma segments in February 2007. In January 2008, the Company acquired ProSyntest AS, a privately held API research and development company located in Tallinn, Estonia. ProSyntest was renamed to Cambrex Tallinn. (Source: 10-K)
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory